How the Yeast Infection Treatment Market Will Grow: Key Trends, Market Size, and Opportunities Beyond 2025
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
Which Primary Drivers Are Supporting the Continued Market Growth of theYeast Infection Treatment Market?
The yeast infection treatment market is likely to be fueled by an increase in autoimmune diseases. In such cases, the body’s immune system wrongly strikes healthy cells, tissues, and organs, jeopardizing normal bodily functions and possibly presenting life-threatening scenarios. To manage and prevent the complications of autoimmune diseases, yeast infection treatments play a crucial role. They address frequent yeast infections tied to specific autoimmune syndromes and may also help regulate the immune response by managing fungal infections in patients with autoimmune issues. For example, in March 2023, the National Institutes of Health, a US federal body responsible for conducting and supporting medical research, projected that around 8.4 million people worldwide were expected to have type 1 diabetes (T1DM) in 2021, with 500,000 new cases reported that year. Additionally, the T1DM population is anticipated to range from 13.5 million to 17.4 million by 2040. Thus, the rise in autoimmune diseases is a key factor powering the yeast infection treatment market’s growth.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13958&type=smp
#What Growth Opportunities Will Drive the Yeast Infection Treatment Market’s CAGR Through 2034?
In the past few years, there has been a significant growth in the market size of yeast infection treatment. Its size is projected to rise from $4.33 billion in 2024 to $4.65 billion in 2025, achieving a compound annual growth rate (CAGR) of 7.5%. The increased occurrence of yeast infections, heightened public awareness about fungal infections, an aging global population, higher healthcare spending worldwide, and the development and approval of fresh antifungal drugs account for the growth that was seen during the historic period.
The market for treatment of yeast infections is predicted to experience robust growth in the upcoming years, expanding to a size of $5.85 billion in 2029 with a CAGR of 5.9%. This predicted growth in the forecast period is due to factors such as the increase in telemedicine utilization for remote medical consultations, personalization in medicine for specific treatments, the introduction of combination therapies for improved effectiveness, an increased focus on natural and herbal treatments, and a concentration on microbiome-centered therapy for managing infections. Key trends for the forecast period encompass advancements in genetic research, the creation of compact and precise diagnostic tools, technological progress in diagnosing and treating yeast infections, growing investment in R&D, and strategic alliances.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13958
How Are Consumer Market Innovations Shaping the Current and Future Landscape of theYeast Infection Treatment Market?
In an effort to stay ahead in the yeast infection treatment market, prominent corporations are focusing on introducing innovative treatments or remedies, such as non-azole oral antifungals. Non-azole oral antifungals are taken orally to combat fungal infections and aren’t part of the azole antifungals class. For example, SCYNEXIS, a biotech company based in the US, received approval from the United States Food and Drug Administration (FDA) in December 2022 for their second indication of BREXAFEMME (ibrexafungerp tablets) a groundbreaking non-azole orally administered antifungal. It is the first therapy of its kind approved by the FDA for the treatment of vaginal yeast infection, also known as vulvovaginal candidiasis (VVC), and for reducing the recurrence of VVC. This innovative alternative has a broad range of efficacy, changing the landscape of the yeast infection treatment market while offering options to patients suffering from recurrent VVC. The recommended dose of BREXAFEMME for VVC treatment is 300 mg (two 150 mg tablets), taken about 12 hours apart which equates to 600 mg (four 150 mg tablets) daily.
Who Are the Key Market Players Influencing the Growth of the Corn and Yeast Infection Treatment Industry?
Major companies operating in the yeast infection treatment market report are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Novartis International AG, Sanofi SA, Thermo Fisher Scientific Inc., Abbott Laboratories, AstraZeneca PLC, Bayer AG, Astellas Pharma Inc., Torrent Pharmaceuticals, Catalent Inc., bioMérieux SA, Cipla, Bruker Corporation, Brundavan Laboratories Private Limited, Glenmark Pharmaceuticals Ltd, Zydus Lifesciences, Prestige Consumer Healthcare Inc., CordenPharma International, Synmedic Laboratories, Basilea Pharmaceutica AG, Jubilant Pharmova Limited, Curia Global Inc., Synexis LLC, Manus Aktteva Biopharma LLP
Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/yeast-infection-treatment-global-market-report
Which Key Market Segments Comprise the Yeast Infection Treatment Market and Drive Its Revenue Growth?
The yeast infection treatment market covered in this report is segmented –
1) By Type: Powders, Creams Or Ointments, Tablets Or Capsules, Other Types
2) By Treatment: Medical Treatment, Surgery
3) By Indication: Genital Candidiasis, Invasive Candidiasis, Oropharyngeal Or Esophageal Candidiasis (Thrush), Other Indications
4) By Route Of Administration: Oral, Topical, IV (Intravenous) Or IM (Intramuscular), Other Routes Of Administration
5) By Application: Retail Pharmacies Or Drug Stores, Hospital Pharmacies, Specialty Stores, Online Sales, Other Applications
Subsegments:
1) By Powders: Antifungal Powders, Medicated Body Powders
2) By Creams Or Ointments: Antifungal Creams, Vaginal Ointments, Topical Creams
3) By Tablets Or Capsules: Oral Antifungal Tablets, Probiotic Capsules, Vaginal Tablets
4) By Other Types: Suppositories, Sprays, Gels
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=13958&type=smp
Which Regions Are Emerging as Leaders in the Yeast Infection Treatment Market?
North America was the largest region in the yeast infection treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the yeast infection treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Reports Similar to the Global Yeast Infection Treatment Market 2025, By The Business Research Company:
Sickle Cell Disease Treatment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/sickle-cell-disease-treatment-global-market-report
Zollinger-Ellison Syndrome Treatment Global Market Report 2024
Neurofibromatosis Treatment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/neurofibromatosis-treatment-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
